Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prempro Insider Trading Case Focuses On Sales Reps

Executive Summary

A Securities & Exchange Commission settlement with two Wyeth sales representatives over alleged insider trading illustrates the complexities of coordinating the release of government-sponsored studies on prescription drugs

You may also be interested in...



Wyeth Prempro Gets Dementia Warning; FDA Considering HRT Class Labeling

FDA is considering hormone replacement therapy class labeling that would incorporate data from a WHI sub-study showing twice the rate of dementia in patients taking Wyeth's Prempro estrogen/progestin combo

NIH Has Room For Improvement In Releasing Study Data – WHI Director

The National Institutes of Health can improve its methods for releasing study data, Women's Health Initiative Director Barbara Alving, MD, said

Prempro Cancer Risk Addressed In 550,000 Physician Letters, Label Review

Wyeth is sending letters to approximately 550,000 physicians as part of a Prempro risk management program to address risks associated with use of the hormone combination for cardiovascular disease and osteoporosis prevention

UsernamePublicRestriction

Register

PS042295

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel